Literature DB >> 12370835

Elevated mutant frequencies and predominance of G:C to A:T transition mutations in Msh6(-/-) small intestinal epithelium.

Sean C Mark1, Linda E Sandercock, H Artee Luchman, Agnes Baross, Winfried Edelmann, Frank R Jirik.   

Abstract

The DNA mismatch repair (MMR) system is primarily responsible for purging newly synthesized DNA of errors incurred during semi-conservative replication. Lesion recognition is initially carried out by one of two heterodimeric protein complexes, MutS(alpha) or MutS(beta). While the former, comprised of MSH2 and MSH6, recognizes mispairs as well as short (1-2 nucleotide) insertions/deletions (IDLs), the latter, made up of MSH2 and MSH3, is primarily responsible for recognizing 2-6 nucleotide IDLs. As most of the functional information on these heterodimers is derived from in vitro studies, it was of interest to study the in vivo consequences of a lack of MutS(alpha). To this end, Big Blue( trade mark ) mice, that carry a lacI(+) transgenic lambda shuttle-phage mutational reporter, were crossed with Msh6(-/-) mice to evaluate the specific contribution of MutS(alpha) to genome integrity. Consistent with the importance of MutS(alpha) in lesion surveillance, small intestine epithelial cell DNA derived from lacI(+) Msh6(-/-) mice exhibited striking increases (average of 41-fold) in spontaneous mutant frequencies. Furthermore, the lacI gene mutation spectrum was dominated by G:C to A:T transitions, highlighting the critical importance of the MutS(alpha) complex in suppressing this frequently observed type of spontaneous mutation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370835     DOI: 10.1038/sj.onc.1205861

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6.

Authors:  Denise Campisi Hegan; Latha Narayanan; Frank R Jirik; Winfried Edelmann; R Michael Liskay; Peter M Glazer
Journal:  Carcinogenesis       Date:  2006-05-25       Impact factor: 4.944

2.  Evidence for mutation showers.

Authors:  Jicheng Wang; Kelly D Gonzalez; William A Scaringe; Kimberly Tsai; Ning Liu; Dongqing Gu; Wenyan Li; Kathleen A Hill; Steve S Sommer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-07       Impact factor: 11.205

3.  Mutation rates, spectra and hotspots in mismatch repair-deficient Caenorhabditis elegans.

Authors:  Dee R Denver; Seth Feinberg; Suzanne Estes; W Kelley Thomas; Michael Lynch
Journal:  Genetics       Date:  2005-02-16       Impact factor: 4.562

4.  Mbd4 inactivation increases Cright-arrowT transition mutations and promotes gastrointestinal tumor formation.

Authors:  Edmund Wong; Kan Yang; Mari Kuraguchi; Uwe Werling; Elena Avdievich; Kunhua Fan; Melissa Fazzari; Bo Jin; Anthony M C Brown; Martin Lipkin; Winfried Edelmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

5.  The relative roles of three DNA repair pathways in preventing Caenorhabditis elegans mutation accumulation.

Authors:  Dee R Denver; Seth Feinberg; Catherine Steding; Matthew D Durbin; Michael Lynch
Journal:  Genetics       Date:  2006-06-18       Impact factor: 4.562

6.  Deficiency of the DNA repair protein nibrin increases the basal but not the radiation induced mutation frequency in vivo.

Authors:  Petra Wessendorf; Jan Vijg; André Nussenzweig; Martin Digweed
Journal:  Mutat Res       Date:  2014-07-11       Impact factor: 2.433

7.  TagRecon: high-throughput mutation identification through sequence tagging.

Authors:  Surendra Dasari; Matthew C Chambers; Robbert J Slebos; Lisa J Zimmerman; Amy-Joan L Ham; David L Tabb
Journal:  J Proteome Res       Date:  2010-04-05       Impact factor: 4.466

8.  A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy.

Authors:  Chris Hunter; Raffaella Smith; Daniel P Cahill; Philip Stephens; Claire Stevens; Jon Teague; Chris Greenman; Sarah Edkins; Graham Bignell; Helen Davies; Sarah O'Meara; Adrian Parker; Tim Avis; Syd Barthorpe; Lisa Brackenbury; Gemma Buck; Adam Butler; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Matthew Gorton; Kristian Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jonathon Hinton; Andy Jenkinson; David Jones; Vivienne Kosmidou; Ross Laman; Richard Lugg; Andrew Menzies; Janet Perry; Robert Petty; Keiran Raine; David Richardson; Rebecca Shepherd; Alexandra Small; Helen Solomon; Calli Tofts; Jennifer Varian; Sofie West; Sara Widaa; Andy Yates; Douglas F Easton; Gregory Riggins; Jennifer E Roy; Kymberly K Levine; Wolf Mueller; Tracy T Batchelor; David N Louis; Michael R Stratton; P Andrew Futreal; Richard Wooster
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

9.  Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease.

Authors:  Truc Nguyen; Pamela M Vacek; Patrick O'Neill; Richard B Colletti; Barry A Finette
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

10.  Role of the mismatch repair gene, Msh6, in suppressing genome instability and radiation-induced mutations.

Authors:  Julio Barrera-Oro; Tzu-Yang Liu; Erin Gorden; Raju Kucherlapati; Changshun Shao; Jay A Tischfield
Journal:  Mutat Res       Date:  2008-04-30       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.